Cyclosporin for the Prevention and Treatment of COVID-19 Disease

Phase 3

Recruiting

• Conditions: covid-19.; Coronavirus infection, unspecified; B34.2

• Registration Number: IRCT20150107020592N22
• Lead Sponsor: Shahid Beheshti University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 15 June 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

covid patients
non-intubated payients
Age between 18-80

Exclusion Criteria

Allergy to cyclosporin
intubated patients

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Improve oxygenation. Timepoint: 0,1,2,3,7after treatment with cyclosporin. Method of measurement: pulse oximeter.;Improve ct scan. Timepoint: seven day after cyclosporine treatment. Method of measurement: CT scan unit.